#NAION
Explore articles, categories and content types about NAION.
Related Articles
Curated entries containing this keyword across available languages.
FDA Issues Blindness Risk Warning for GLP-1 Weight Loss Drugs
The US Food and Drug Administration (FDA) has mandated the addition of warnings regarding a rare eye condition that can lead to blindness, known as NAION, to the labels of GLP-1 weight loss and diabetes medications such as Ozempic and Wegovy.
News
Science & Health
